Sun Pharmaceutical Industries Ltd 2022 SR
The report details Sun Pharma's ESG performance for FY22, highlighting its commitment to climate action and social responsibility. Key achievements include sourcing 31% of energy from renewable sources and having 18 sites achieve Zero Liquid Discharge status. The company set a target to reduce Scope 1 and 2 emissions by 35% by 2030. Socially, Sun Pharma reached 6.5 million beneficiaries through CSR programs and focused on employee well-being and safety. The report follows GRI Standards and includes external assurance by DNV.
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2022
Type: SR
Pages: 97
Back to company
Sun Pharmaceutical Industries Ltd
Sustainability Report
The report details Sun Pharma's ESG performance for FY22, highlighting its commitment to climate action and social responsibility. Key achievements include sourcing 31% of energy from renewable sources and having 18 sites achieve Zero Liquid Discharge status. The company set a target to reduce Scope 1 and 2 emissions by 35% by 2030. Socially, Sun Pharma reached 6.5 million beneficiaries through CSR programs and focused on employee well-being and safety. The report follows GRI Standards and includes external assurance by DNV.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Published
Jul 27, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees